Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Fractures and Osteoporosis in Patients With Diabetes With Charcot Foot

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901-907

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Effect of liraglutide on expression of inflammatory genes in type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Farsad Afshinnia
  • Thekkelnaycke M Rajendiran
  • Chenchen He
  • Jaeman Byun
  • Daniel Montemayor
  • Manjula Darshi
  • Jana Tumova
  • Jiwan Kim
  • Christine P Limonte
  • Rachel G Miller
  • Tina Costacou
  • Trevor J Orchard
  • Tarunveer S Ahluwalia
  • Peter Rossing
  • Janet K Snell-Bergeon
  • Ian H de Boer
  • Loki Natarajan
  • George Michailidis
  • Kumar Sharma
  • Subramaniam Pennathur
View graph of relations

OBJECTIVES: Patients with type 1 diabetes (T1D) exhibit modest lipid abnormalities as measured by traditional metrics. This study aimed to identify lipidomic predictors of rapid decline of kidney function in T1D.

RESEARCH DESIGN AND METHODS: In a case-control study, 817 patients with T1D from three large cohorts were randomly split into training and validation subsets. Case was defined as >3 mL/min/1.73 m2 per year decline in estimated glomerular filtration rate (eGFR), while control was defined as <1 mL/min/1.73 m2 per year decline over a minimum 4-year follow-up. Lipids were quantified in baseline serum samples using a targeted mass spectrometry lipidomic platform.

RESULTS: At individual lipids, free fatty acid (FFA)20:2 was directly and phosphatidylcholine (PC)16:0/22:6 was inversely and independently associated with rapid eGFR decline. When examined by lipid class, rapid eGFR decline was characterized by higher abundance of unsaturated FFAs, phosphatidylethanolamine (PE)-Ps, and PCs with an unsaturated acyl chain at the sn1 carbon, and by lower abundance of saturated FFAs, longer triacylglycerols, and PCs, PEs, PE-Ps, and PE-Os with an unsaturated acyl chain at the sn1 carbon at eGFR ≥90 mL/min/1.73 m2. A multilipid panel consisting of unsaturated FFAs and saturated PE-Ps predicted rapid eGFR decline better than individual lipids (C-statistic, 0.71) and improved the C-statistic of the clinical model from 0.816 to 0.841 (P = 0.039). Observations were confirmed in the validation subset.

CONCLUSIONS: Distinct from previously reported predictors of GFR decline in type 2 diabetes, these findings suggest differential incorporation of FFAs at the sn1 carbon of the phospholipids' glycerol backbone as an independent predictor of rapid GFR decline in T1D.

Original languageEnglish
JournalDiabetes Care
Volume44
Issue number9
Pages (from-to)2098-2106
Number of pages9
ISSN1935-5548
DOIs
Publication statusPublished - Sep 2021

ID: 66944421